TOMI Environmental Solutions Receives UK Approval for Disinfection Technology
TOMI Environmental Solutions Inc. has seen a significant price increase of 21.26% in pre-market trading as it crosses above the 5-day SMA.
The company received official authorization for its Binary Ionization Technology (BIT) solution from the Health and Safety Executive in Great Britain, marking a crucial regulatory milestone that enhances its competitive position in the disinfection industry. This approval allows for room fogging and handheld spray applications across various sectors, including healthcare and commercial, which is expected to significantly boost sales potential. COO Elissa J. Shane expressed optimism about the approval and anticipates further expansion opportunities in Europe.
This regulatory approval not only strengthens TOMI's market presence but also positions the company favorably against competitors in the disinfection sector, potentially leading to increased revenue and market share.
Trade with 70% Backtested Accuracy
Analyst Views on TOMZ

No data
About TOMZ
About the author

- Surge in Market Demand: TOMI's SteraMist iHP technology is widely trusted by healthcare coalitions and hospital networks globally, with frontline customers significantly increasing investments in system maintenance and training support, highlighting the company's critical role in public health readiness.
- World Cup Prospects: With an estimated 6.5 million fans from over 100 countries attending the 2026 North America World Cup, healthcare facilities and stadiums are aggressively upgrading sanitation protocols to address highly contagious threats like measles, further driving the procurement of SteraMist systems.
- Biosecurity Investment Trend: As global travel recovers, governments and facility operators increasingly recognize biosecurity as a vital component of public infrastructure, with expectations of significantly greater investments in biosecurity preparedness over the next decade to address complex international events.
- Long-term Market Opportunity: TOMI's CEO emphasizes that the World Cup serves not only as a major sporting event but also as a crucial reminder of the importance of biosecurity infrastructure, potentially creating multi-billion-dollar market opportunities across transportation, hospitality, food systems, and more.
- Growing Market Demand: As threats from emerging pathogens like Ebola, hantavirus, and norovirus intensify, TOMI Environmental Solutions anticipates a significant increase in demand for automated biosecurity solutions, driving the application of its SteraMist technology in public health and agriculture sectors.
- Drone Technology Deployment: TOMI plans to leverage drone-enabled deployment of SteraMist technology to address the limitations of traditional disinfection methods in large-scale environments, which is expected to significantly enhance response speed and reduce labor costs, thereby improving operational efficiency.
- AI and Robotics Integration: TOMI believes that automated disinfection systems combining artificial intelligence and robotics will become crucial for future public health and infrastructure protection, enabling more frequent and widespread disinfection, thus enhancing overall safety.
- Strategic Market Positioning: TOMI's strategy places it at the intersection of multiple high-growth markets, including artificial intelligence, drones, and biosecurity, which is expected to create long-term growth opportunities for the company, especially as automated and intelligent infrastructure becomes increasingly vital.
- Surge in Demand: As national public health agencies report surges in community norovirus and high-risk viral threats like Ebola, the demand for TOMI's SteraMist ionized Hydrogen Peroxide technology has significantly increased, highlighting the company's critical role in the biosecurity solutions market.
- Technological Advantage: The SteraMist technology effectively disinfects large spaces in a short time, minimizing operational downtime, particularly in high-traffic areas such as hospitals, schools, and transportation hubs, thereby enhancing customer trust in infection control measures.
- Global Expansion Potential: TOMI's technology is applicable across various mission-critical industries, and as institutions transition towards ongoing biosecurity strategies, a multi-year expansion in global environmental decontamination spending is anticipated, further solidifying the company's market leadership.
- Addressing New Challenges: Following the COVID-19 pandemic, TOMI's SteraMist platform gained significant attention, and with norovirus and Ebola threats back in the spotlight, a long-term demand cycle for advanced infection control technologies is being driven.
- Market Expansion Milestone: TOMI Environmental Solutions has secured regulatory approval for its Binary Ionization Technology (BIT) in Austria and Italy, adding to its existing authorizations in countries like the Netherlands, Belgium, and Denmark, marking a significant step in the company's European market expansion.
- Accelerated Market Rollout: Under the EU's Biocidal Products Regulation (BPR), TOMI can leverage approvals in one member state to streamline mutual recognition processes in others, significantly speeding up market rollout, with plans to enter France, Ireland, and more.
- Product Certification Advantage: BIT technology has been officially authorized as a PT2 disinfectant in the Netherlands since March 2026, enhancing TOMI's competitive edge across healthcare and commercial sectors, addressing the growing demand for effective disinfection solutions.
- Increased Industry Impact: TOMI's products and services cater to various commercial structures, including hospitals and schools, and with the technology's expansion, the company is poised to achieve higher customer acquisition rates and sales growth in the European market, driving overall business development.
- Strategic Transition: TOMI Environmental Solutions has signed a purchase order for a custom SteraMist Hybrid system with a food producer, marking a strategic shift from portable technology to fully integrated facility protection, which is expected to significantly enhance food safety standards and reduce contamination risks.
- Technology Upgrade: The food producer adopted the SteraMist SteraPak in 2024 for pathogen control, and after years of successful use, it is now expanding operations by utilizing the SteraMist Hybrid system as a permanent infrastructure component to ensure ongoing compliance and mitigate production downtime risks.
- Efficient Disinfection: The SteraMist Hybrid system provides an automated solution that treats facility environments more efficiently than manual methods, achieving rapid pathogen deactivation without leaving caustic residues, a critical requirement for maintaining high-output food processing certifications.
- Market Expansion: TOMI COO Elissa J. Shane stated that the progression from a mobile unit to a custom Hybrid system reflects a key growth pattern within the food and beverage sector, indicating the company's commitment to enhancing supply chain integrity while supporting partners' expansion goals.
- Emerging Market Opportunity: TOMI Environmental Solutions highlights that the global food safety market exceeds $1 trillion, with rising concerns over pathogens like Ebola and Norovirus driving food producers and distributors to seek advanced disinfection technologies.
- Technological Edge: The SteraMist® platform offers scalable decontamination solutions that can be effectively deployed in large facilities and complex environments, enhancing biosecurity as food safety standards become increasingly stringent.
- Growth Projections: Industry analysts project continued growth in food safety, sanitation, and biosecurity markets, with governments and private enterprises investing in technologies to reduce contamination risks, positioning TOMI to leverage its extensive service experience for market entry.
- Strategic Positioning: As public awareness of infectious disease outbreaks rises, TOMI believes food safety is emerging as a major growth driver, with SteraMist® technology uniquely positioned to meet evolving market demands.




